Medical Hyperspectral Imaging Market by Application (Cancer, Cardiac Disease, Diabetic Foot, Retinal Disease, Tissue Pathology, Image-Guided Surgery) by End User (Diagnostic Centers, Hospitals, Research Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 16-Mar-2021 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5969 Status : Published

The medical hyperspectral imaging market is set for a rapid growth over the forecast period. In terms of revenue, the global medical hyperspectral imaging market accounted for USD 2.15 Billion in 2019 and is expected to reach USD 5.80 Billion by 2026, growing at a CAGR of 15.24%

Description

The medical hyperspectral imaging market is set for a rapid growth over the forecast period. In terms of revenue, the global medical hyperspectral imaging market accounted for USD 2.15 Billion in 2019 and is expected to reach USD 5.80 Billion by 2026, growing at a CAGR of 15.24%

Global Medical Hyperspectral Imaging Market: Overview

Hyperspectral Imaging (HSI), also known as imaging spectrometer are derived from remote sensing and has been explored for various NASA applications. HSI has been used in a variety of fields, including archaeology and art conservation, food quality and safety control, plant and water resource management, forensic medicine, biomedicine, crime scene identification, and so on, because of its ability to acquire two-dimensional images across a broad range of electromagnetic spectrum.

HSI, as a revolutionary imaging modality for medical use, has a huge amount of potential for surgical guidance and noninvasive disease diagnosis. When light passes through biological tissue, it is scattered several times due to the inhomogeneity of biological structures and is absorbed mainly by haemoglobin, melanin, and water. The fluorescence, absorption, and scattering characteristics of tissue are thought to change as disease progresses. As a result, HSI collects quantitative diagnostic knowledge about tissue pathology in the form of absorbed, fluorescent, and transmitted light from tissue. Developments in hyperspectral cameras, image processing techniques, and computational capacity have enabled a slew of new medical applications in recent years.

HSI can provide near-real-time images of biomarker content, such as absorption spectra of oxy/deoxy-hemoglobin, as well as tissue pathophysiology assessments based on the spectral characteristics of different tissues. Thus, HSI is becoming more widely used in image-guided surgery and medical diagnosis. HSI has been used in the diagnosis of hemorrhagic shock, the evaluation of peripheral artery disease, the early detection of dental caries, the rapid characterization of kidney stone forms, the detection of laryngeal disorders, and many other applications.

Global Medical Hyperspectral Imaging Market: Growth Factors

The key factors driving the demand for medical hyperspectral imaging market include, the ageing population and the rising occurrence of chronic diseases. In addition, the launch of portable and handheld hyperspectral imaging systems with high operability and protection, coupled with growing number of diagnostic procedures, are expected to boost the demand for global medical hyperspectral imaging market.

The global medical hyperspectral imaging market has enormous growth opportunities in both developed and developing regions. Medical hyperspectral imaging systems are being developed by the manufacturers to support image analysis and speed up the process of various imaging facilities, mainly during surgeries. Imaging systems for high-quality imaging, screening and diagnostic testing are rapidly implemented due to increased access and support from government and other healthcare agencies, in particular in the United States, Canada, France, Germany and the United Kingdom.

Global Medical Hyperspectral Imaging Market: Segmentation

HSI has an enormous potential for disease screening, identification and diagnosis because it is capable of detecting biochemical changes due to the development of disorders, such as cancer cell metabolism.

HSI has shown promising potential in the diagnosis of cancers of the cervix, breast, gastrointestine, colon, skin, ovary, prostate, urothelial carcinoma, esophagea, oral tissue, tongue, trachea, brain, and lymph nodes as compared to optical spectroscopy, that measures tissue spectra point-by-point.

Mechanical access or invasive biopsy of the retina is typically not possible due to the fragile nature of the eye. As a result, optical imaging techniques are heavily used in the modern diagnosis of retinal disease. To allow optical imaging of the eyes, an HSI system is typically combined with a fundus camera.

Global Medical Hyperspectral Imaging Market: Regional Analysis

By Geography, the medical hyperspectral imaging market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

In North America, the United States and Canada are the leading countries due to the largest number of diagnostic cases in 2020. This field is dominated by the overall presence of hyperspectral imaging in healthcare and has the most diversified instruments available on the market. The region has the largest proportion of the aging population with many individuals suffering from chronic diseases such as neurovascular disorders, CVD, orthopaedic surgery, and other urology-related disorders. This has enabled most vendors to maintain and expand over the timeframe and to maintain their product presence in the market.

Europe is the second leading region and held a significant market share in 2020. The demand in Europe has primarily been driven by advances in the technology of medical devices. Some of the key factors such as an increase in the prevalence of diseases, the continuous implementation of new technology and an increase in the ageing population are driving the demand in the region. Germany, France, the United Kingdom and Italy are the leading countries in Europe.

Global Medical Hyperspectral Imaging Market: Competitive Players

The major players in the global medical hyperspectral imaging market include Headwall Photonics, Inc., Norsk Elektro Optikk AS, SPECIM, SPECTRAL IMAGING LTD., IMEC and Surface Optics Corporation among others.

The report segment of global medical hyperspectral imaging market are as follows:

Global Medical Hyperspectral Imaging Market: Application Segment Analysis

  • Cancer
  • Cardiac Disease
  • Diabetic Foot
  • Retinal Disease
  • Tissue Pathology
  • Image-Guided Surgery

Global Medical Hyperspectral Imaging Market: End User Segment Analysis

  • Diagnostic Centers
  • Hospitals
  • Research Centers

Global Medical Hyperspectral Imaging Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Medical Hyperspectral Imaging Market, 2016-2026, (USD Billion)
    • 2.2. Medical Hyperspectral Imaging Market: Market snapshot
  • Chapter 3. Global Medical Hyperspectral Imaging Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry Ecosystem Analysis
    • 3.3. Technulogy Landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & Sustainability
    • 3.8. Regulatory Landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Medical Hyperspectral Imaging Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Application Segment
      • 3.11.2. Market Attractiveness Analysis by End User Segment
  • Chapter 4. Global Medical Hyperspectral Imaging Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Medical Hyperspectral Imaging Market – Application Segment Analysis
    • 5.1. Global Medical Hyperspectral Imaging Market Revenue Share, by Application, 2019 & 2026 (USD Billion)
    • 5.2. Global Medical Hyperspectral Imaging Market by Cancer, 2016 – 2026 (USD Billion)
    • 5.3. Global Medical Hyperspectral Imaging Market by Cardiac Disease, 2016 – 2026 (USD Billion)
    • 5.4. Global Medical Hyperspectral Imaging Market by Diabetic Foot, 2016 – 2026 (USD Billion)
    • 5.5. Global Medical Hyperspectral Imaging Market by Retinal Disease, 2016 – 2026 (USD Billion)
    • 5.6. Global Medical Hyperspectral Imaging Market by Tissue Pathulogy, 2016 – 2026 (USD Billion)
    • 5.7. Global Medical Hyperspectral Imaging Market by Image-Guided Surgery, 2016 – 2026 (USD Billion)
  • Chapter 6. Medical Hyperspectral Imaging Market – End User Segment Analysis
    • 6.1. Global Medical Hyperspectral Imaging Market Revenue Share, by End User, 2019 & 2026 (USD Billion)
    • 6.2. Global Medical Hyperspectral Imaging Market by Diagnostic Centers, 2016 – 2026 (USD Billion)
    • 6.3. Global Medical Hyperspectral Imaging Market by Hospitals, 2016 – 2026 (USD Billion)
    • 6.4. Global Medical Hyperspectral Imaging Market by Research Centers, 2016 – 2026 (USD Billion)
  • Chapter 7. Medical Hyperspectral Imaging Market - Regional Analysis
    • 7.1. Global Medical Hyperspectral Imaging Market: Regional Overview
      • 7.1.1. Global Medical Hyperspectral Imaging Market Revenue Share, By Region, 2019 & 2026 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Medical Hyperspectral Imaging Market Revenue 2016 – 2026 (USD Billion)
      • 7.2.2. North America Medical Hyperspectral Imaging Market Revenue, By Application, 2016 – 2026 (USD Billion)
      • 7.2.3. North America Medical Hyperspectral Imaging Market Revenue, By End User, 2016 – 2026 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.2.4.2. U.S. Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.2.5. Canada
        • 7.2.5.1. Canada Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.2.5.2. Canada Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.2.6. Mexico
        • 7.2.6.1. Mexico Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.2.6.2. Mexico Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Medical Hyperspectral Imaging Market Revenue 2016 – 2026 (USD Billion)
      • 7.3.2. Europe Medical Hyperspectral Imaging Market Revenue, By Application, 2016 – 2026 (USD Billion)
      • 7.3.3. Europe Medical Hyperspectral Imaging Market Revenue, By End User, 2016 – 2026 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. UK Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.4.2. UK Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.5.2. France Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.6.2. Germany Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.7. Italy
        • 7.3.7.1. Italy Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.7.2. Italy Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.8. Spain
        • 7.3.8.1. Spain Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.8.2. Spain Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.9. Russia
        • 7.3.9.1. Russia Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.9.2. Russia Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.3.10.2. Rest of Europe Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Medical Hyperspectral Imaging Market Revenue 2016 – 2026 (USD Billion)
      • 7.4.2. Asia Pacific Medical Hyperspectral Imaging Market Revenue, By Application, 2016 – 2026 (USD Billion)
      • 7.4.3. Asia Pacific Medical Hyperspectral Imaging Market Revenue, By End User, 2016 – 2026 (USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.4.2. China Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.5.2. Japan Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.6.2. India Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.4.7. Australia
        • 7.4.7.1. Australia Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.7.2. Australia Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.8.2. South Korea Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.4.9. Rest of Asia Pacific
        • 7.4.9.1. Rest of Asia Pacific Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.4.9.2. Rest of Asia Pacific Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Medical Hyperspectral Imaging Market Revenue 2016 – 2026 (USD Billion)
      • 7.5.2. Latin America Medical Hyperspectral Imaging Market Revenue, By Application, 2016 – 2026 (USD Billion)
      • 7.5.3. Latin America Medical Hyperspectral Imaging Market Revenue, By End User, 2016 – 2026 (USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.5.4.2. Brazil Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.5.5. Argentina
        • 7.5.5.1. Argentina Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.5.5.2. Argentina Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.5.6.2. Rest of Latin America Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa Medical Hyperspectral Imaging Market Revenue 2016 – 2026 (USD Billion)
      • 7.6.2. Middle East & Africa Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
      • 7.6.3. Middle East & Africa Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.6.4. GCC Countries
        • 7.6.4.1. GCC Countries Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.6.4.2. GCC Countries Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.6.5. South Africa
        • 7.6.5.1. South Africa Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.6.5.2. South Africa Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
      • 7.6.6. Rest of MEA
        • 7.6.6.1. Rest of MEA Medical Hyperspectral Imaging Market Revenue, by Application, 2016 – 2026 (USD Billion)
        • 7.6.6.2. Rest of MEA Medical Hyperspectral Imaging Market Revenue, by End User, 2016 – 2026 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Headwall Photonics, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfulio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. *Same information will be provided for below mentioned companies*
      • 8.2.1. Norsk Elektro Optikk AS
      • 8.2.2. SPECIM, SPECTRAL IMAGING LTD.
      • 8.2.3. IMEC
      • 8.2.4. Surface Optics Corporation
      • 8.2.5. Others

Methodology


Frequently Asked Questions

The key factors driving the demand for medical hyperspectral imaging market include, the ageing population and the rising occurrence of chronic diseases. In addition, the launch of portable and handheld hyperspectral imaging systems with high operability and protection, coupled with growing number of diagnostic procedures, are expected to boost the demand for global medical hyperspectral imaging market.

According to Zion Market Research, the medical hyperspectral imaging market is expected to generate revenue of around USD 5.80 Billion by the end of 2026, growing at a CAGR of 15.24%.

In North America, the United States and Canada are the leading countries due to the largest number of diagnostic cases in 2020. This field is dominated by the overall presence of hyperspectral imaging in healthcare and has the most diversified instruments available on the market. The region has the largest proportion of the aging population with many individuals suffering from chronic diseases such as neurovascular disorders, CVD, orthopaedic surgery, and other urology-related disorders. This has enabled most vendors to maintain and expand over the timeframe and to maintain their product presence in the market.

The major players in the global medical hyperspectral imaging market include Headwall Photonics, Inc., Norsk Elektro Optikk AS, SPECIM, SPECTRAL IMAGING LTD., IMEC and Surface Optics Corporation among others.
 

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com